Your browser doesn't support javascript.
loading
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.
John, Binu V; Bastaich, Dustin; Webb, Gwilym; Brevini, Teresa; Moon, Andrew; Ferreira, Raphaella D; Chin, Allison M; Kaplan, David E; Taddei, Tamar H; Serper, Marina; Mahmud, Nadim; Deng, Yangyang; Chao, Hann-Hsiang; Sampaziotis, Fotios; Dahman, Bassam.
Afiliação
  • John BV; Division of Gastroenterology and Hepatology, Miami VA Medical System, Miami, Florida, USA.
  • Bastaich D; Division of Digestive Health and Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Webb G; Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Brevini T; Cambridge Liver Unit, Cambridge University Hospital, NHS Foundation Trust, Cambridge, UK.
  • Moon A; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.
  • Ferreira RD; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Chin AM; Division of Gastroenterology and Hepatology, Miami VA Medical System, Miami, Florida, USA.
  • Kaplan DE; Herbert Wertheim Florida International University, Miami, Florida, USA.
  • Taddei TH; Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Serper M; Section of Gastroenterology and Hepatology, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
  • Mahmud N; Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut, USA.
  • Deng Y; Section of Gastroenterology, VA Connecticut Healthcare System, West Haven, Connecticut, USA.
  • Chao HH; Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Sampaziotis F; Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dahman B; Department of Health Behavior and Policy, Virginia Commonwealth University, Richmond, Virginia, USA.
J Intern Med ; 293(5): 636-647, 2023 05.
Article em En | MEDLINE | ID: mdl-37018129
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: COVID-19 / Cirrose Hepática Biliar Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Intern Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: COVID-19 / Cirrose Hepática Biliar Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Intern Med Ano de publicação: 2023 Tipo de documento: Article